SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-012708
Filing Date
2019-03-05
Accepted
2019-03-05 07:30:28
Documents
4
Period of Report
2019-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-5831_18k.htm 8-K 30247
2 EX-2.1 a19-5831_1ex2d1.htm EX-2.1 865835
3 EX-99.1 a19-5831_1ex99d1.htm EX-99.1 34374
4 GRAPHIC g58311mmi001.jpg GRAPHIC 4058
  Complete submission text file 0001104659-19-012708.txt   937503
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 19656597
SIC: 2834 Pharmaceutical Preparations